Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
Bio-Rad Laboratories (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, has announced its participation in J.P. Morgan's 43rd Annual Healthcare Conference. The company's leadership team, including CEO Norman Schwartz, COO Jon DiVincenzo, and CFO Roop K. Lakkaraju, will conduct one-on-one meetings with analysts and investors during the conference, which is scheduled to take place in San Francisco, CA from January 13-16, 2025.
Bio-Rad Laboratories (NYSE: BIO e BIO.B), un leader globale nella ricerca biomedica e nei prodotti di diagnostica clinica, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale sulla Sanità di J.P. Morgan. Il team dirigenziale dell'azienda, composto dal CEO Norman Schwartz, dal COO Jon DiVincenzo e dal CFO Roop K. Lakkaraju, condurrà incontri individuali con analisti e investitori durante la conferenza, che si terrà a San Francisco, CA dal 13 al 16 gennaio 2025.
Bio-Rad Laboratories (NYSE: BIO y BIO.B), un líder global en investigación en ciencias de la vida y productos de diagnóstico clínico, ha anunciado su participación en la 43ª Conferencia Anual de Salud de J.P. Morgan. El equipo directivo de la empresa, que incluye al CEO Norman Schwartz, COO Jon DiVincenzo y CFO Roop K. Lakkaraju, realizará reuniones uno a uno con analistas e inversores durante la conferencia, que se llevará a cabo en San Francisco, CA del 13 al 16 de enero de 2025.
Bio-Rad Laboratories (NYSE: BIO 및 BIO.B)는 생명 과학 연구 및 임상 진단 제품의 글로벌 리더로서 J.P. Morgan의 제43회 연례 건강 회의에 참여할 것이라고 발표했습니다. 회사 경영진인 CEO Norman Schwartz, COO Jon DiVincenzo, CFO Roop K. Lakkaraju가 이번 회의 기간 동안 분석가 및 투자자와의 일대일 미팅을 진행할 예정이며, 회의는 2025년 1월 13일부터 16일까지 샌프란시스코, CA에서 열립니다.
Bio-Rad Laboratories (NYSE: BIO et BIO.B), un leader mondial dans la recherche en sciences de la vie et les produits de diagnostic clinique, a annoncé sa participation à la 43e Conférence Annuelle sur la Santé de J.P. Morgan. L'équipe dirigeante de l'entreprise, comprenant le CEO Norman Schwartz, le COO Jon DiVincenzo et le CFO Roop K. Lakkaraju, rencontrera individuellement des analystes et investisseurs durant la conférence, qui se déroulera à San Francisco, CA du 13 au 16 janvier 2025.
Bio-Rad Laboratories (NYSE: BIO und BIO.B), ein globaler Marktführer in der Lebenswissenschaftforschung und klinischen Diagnostikprodukten, hat seine Teilnahme an der 43. jährlichen Gesundheitskonferenz von J.P. Morgan bekannt gegeben. Das Führungsteam des Unternehmens, einschließlich CEO Norman Schwartz, COO Jon DiVincenzo und CFO Roop K. Lakkaraju, wird während der Konferenz, die vom 13. bis 16. Januar 2025 in San Francisco, CA stattfindet, Einzelgespräche mit Analysten und Investoren führen.
- None.
- None.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250102060278/en/
Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com
Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com
Source: Bio-Rad Laboratories, Inc.
FAQ
When is Bio-Rad (BIO) participating in the J.P. Morgan Healthcare Conference 2025?
Which Bio-Rad executives will attend the J.P. Morgan Healthcare Conference 2025?
What type of meetings will Bio-Rad (BIO) conduct at the J.P. Morgan Healthcare Conference 2025?
Where will the J.P. Morgan Healthcare Conference 2025 featuring Bio-Rad (BIO) take place?
